Nomura Micro Science reported a sharp decline in first-quarter revenue and operating profit for the fiscal year ending March 2027, at ¥9.2 billion and ¥600 million, respectively, while orders surged to ¥38.9 billion. Full-year revenue is forecast at ¥97.0 billion and operating profit at ¥16.0 billion.
According to Nomura Micro Science's earnings report for the first quarter of the fiscal year ending March 2027 (April–June 2026), revenue was ¥9.2 billion, down 25.8% year on year, while operating profit was ¥600 million, down 54.4%. Orders, however, surged 783.4% to ¥38.9 billion, and full-year revenue is forecast at ¥97.0 billion, with operating profit expected to rise significantly to ¥16.0 billion.
In terms of share-price movements, the stock fell from ¥3,780 to ¥3,070 between 13 and 15 October, a decline of 18.8% in 2 days. It then rebounded to ¥3,175 on 16 October, gaining ¥105, or 3.42%, from the previous day. Over the latest 5 trading days, the rebound from the recent high remains substantial, and the stock continues to recover following its sharp decline.
The next earnings announcement is scheduled for 13 November 2026. The earnings report summary identifies the substantial increase in orders as a factor supporting future revenue recovery despite the sharp decline in revenue and profit described above. Long-term performance checkpoints include increased orders for large-scale water treatment equipment and expanded maintenance revenue, while regional expansion, the promotion of prefabricated construction, and entry into the chemical solutions field are cited as medium- to long-term growth drivers.